Emily’s Entourage (EE), an innovative 501(c)(3) organization accelerating new treatments and a cure for the final 10% of people with cystic fibrosis (CF) that do not benefit from existing CFTR modulator therapies, today announced the appointment of David A. Waltz, MD, as the organization’s first Chief Medical Officer (CMO).

https://www.emilysentourage.org/emilys-entourage-appoints-david-a-waltz-md-as-first-chief-medical-officer/?blm_aid=366899202